156-157 / 427
(U)HPLC‐UV/DAD
•
Screening/quantitation of known adulterants
•
Detection of structurally similar compounds
Li it d id tifi ti
•
m e en ca on
•
Possibility to combine with LC‐MS for improved
screening and identification
Examples:
‐
Zou et al., J. Chromatogr. A 1104 (2006) 113–122
(6 compounds)
‐
Sacré et al., J. Chromatogr. A 1218 (2011) 6439–6447
(8 compounds)
‐
Sakamoto et al., J. AOAC Int. 95 (2012) 1048‐1052
(novel analog identification)